For weight loss, off-label GLP-1s are increasingly the chosen ones | AMCP 2023March 24th 2023
They are the trendy way to lose weight and payers have been noticing an increase in GLP-1 claims. An analysis of the pharmacy and healthcare claims of a small commercial health plan in Texas documents the growth in the off-label usage of the GLP-1s, such as Ozempic, for weight loss.
10 Takeaways from Douglas Long, MBA | AMCP 2023March 23rd 2023
The IQVIA vice president sees trouble for generics manufacturers, but painted a bright picture for biosimilars during his keynote address at the annual meeting of the Academy of Managed Care Pharmacy (AMCP).
It's Not Just the P&T Committee. Payers Are Putting Value Assessment Committees, Filters on Drug Coverage Decisions | AMCP 2023March 22nd 2023
Costs have always figured into drug coverage decisions, but value assessments have become a separate and more formalized part of the process at payer organizations, said members of a panel on value frameworks at the 2023 AMCP annual meeting. The Institute for Clinical and Economic Review (ICER) came up often during the discussion.
Examining Adverse Pregnancy Outcomes in People Living with HIV
The known benefits of antiretroviral therapy (ART) in pregnant persons living with HIV outweigh the risks, which include low-birth weight and metabolic complications for the pregnant person, says the lead author of a review article ART and adverse outcomes published in the New England Journal of Medicine.
Challengers of the Status Quo In Physician Payment — Paying Primary Care Physicians More Than SpecialistsMarch 20th 2023
This part of the month's cover story series features Suzanne Delbanco, Ph.D., M.P.H., executive director of the Catalyst for Payment Reform, who has the provocative suggestion of flipping physician payment so primary care physicians are paid more, not less, than specialists. “We spend so much more on specialists than we do on primary care. While a specialist can help people who are already ill, primary care doctors can help people from becoming ill,” she says.
MS Group Asks WHO to Add Three Disease-Modifying Treatments to List of Essential MedicinesMarch 20th 2023
The Multiple Sclerosis International Federation has applied to have Rituxan, Mavenclad and Copaxone added to the World Health Organization’s list of essential medications.
Chase the Anomalies to Find the Big Ideas, Advises Keynoter BahcallMarch 19th 2023
In his keynote at the annual meeting of the American Academy of Dermatology Association Safi R. Bahcall, Ph.D., a physicist and entrepreneur, spoke about how seemingly crazy ideas can lead to breakthroughs.
Clinical Trial Addresses the Lack of Diversity in Dermatology ResearchMarch 19th 2023
VISIBLE is focused on answering data gaps in people of color with psoriasis. Lead investigator Andrew F. Alexis, M.D., hopes the study will generate data to help address care gaps and inform future best practices in diversity research in dermatology.
Cancer Treatment's Checkpoint Inhibitors Are Causing Skin-Related Side EffectsMarch 18th 2023
Checkpoint inhibitors, such as Keytruda (pembrolizumab) and Opdivo (nivolumab), are playing a major role in cancer treatment. But they also produce side effects that affect the skin. Steven Chen, M.D., M.P.H., M.H.P. Ed., said dermatologists need to work with oncologists to manage the side effects so patients can stay on checkpoint inhibitors.
Treatment of Atopic Dermatitis and Psoriasis in People Who Are Pregnant: It’s ComplicatedMarch 18th 2023
Women who are pregnant don’t have to stop all of their treatments during pregnancy. Some can be safely treated for their psoriasis or eczema, according to a presentation today at the annual meeting of the American Academy of Dermatology.
Contact Dermatitis Can Be a Complication of Metal ImplantsMarch 17th 2023
Although not a common complication of hip, knee and other metal implants, the number of allergic reactions is growing, partly the number of joint replacements is growing, according to a presentation at the annual meeting of the American Academy of Dermatology. Nickel is the most common contact allergen.